Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with RAS mutations.
Jihyun Park, Hyejoo Park, J. Byun, Junshik Hong, Dong-Yeop Shin, Y. Koh, S. Yoon
Oncology Letters